2022 · The journal of obstetrics and gynaecology research · paywalled
A comparison of high-risk human papillomavirus DNA detection between urine and cervical sample testing in women with abnormal Pap smears
Punyashthira et al.
The finding, in our words
Urine testing for high-risk HPV achieved 86.2% sensitivity for detecting high-grade cervical lesions, slightly below the 94.8% sensitivity of cervical samples, while patient satisfaction was significantly higher with self-collected urine. High agreement for HPV 16/18 genotypes between the two methods supports urine as a viable alternative for decentralised cervical screening.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.